GH-axis + recovery stack

GHRP-6 + Pentadeca Arginate (PDA) stack

A research-context overview of stacking GHRP-6 with Pentadeca Arginate (PDA): the rationale, complementary benefits, side-effect overlap, and pharmacokinetic considerations. Educational only — never a recommendation.

Why this stack?

Pairing a Performance peptide like GHRP-6 with a Recovery peptide like Pentadeca Arginate (PDA) is one of the most common stack archetypes in the research literature. The Performance compound drives the GH/IGF-1 axis or anabolic signaling; the Recovery compound shortens the soft-tissue and inflammation tax of training, letting the anabolic signal land on healthier tissue. The two work on independent pathways, so timing concerns are minimal — most researchers dose them on separate clocks.

Performance

GHRP-6

GH Stimulator.

Key benefits

  • Increases GH release
  • Increases appetite
  • Recovery

Side effects to watch

  • Extreme hunger
  • Water retention
Reference dose
100-300 mcg · 2-3 times daily
Recovery

Pentadeca Arginate (PDA)

Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.

Key benefits

  • Tendon and ligament healing
  • Better stability than BPC-157 acetate
  • Anti-inflammatory

Side effects to watch

  • Injection-site irritation
  • Limited human trial data
Reference dose
250-500 mcg · 1-2x daily SC

Half-life considerations

Reference half-life data for one or both of these compounds is not in our table — see the individual peptide profiles for cited PK ranges.

Profile
GHRP-6
Profile
Pentadeca Arginate (PDA)
Compare
GHRP-6 vs Pentadeca Arginate (PDA)

Educational use only

This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.